𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study

✍ Scribed by Prakash B Chougule; Steve Suk; Quyen D. Chu; Louis Leone; Peter T. Nigri; Robert McRae; Mary Lekas; Anthony Barone; Dinesh Bhat; Joseph Bellino


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
552 KB
Volume
74
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase II study of piritrexim in patien
✍ Wu-Ching Uen; Andrew T. Huang; Robert Mennel; Stephen E. Jones; Monica B. Spauld πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 347 KB πŸ‘ 3 views

Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the

Intraoperative radiation therapy as an β€œ
✍ Laura Marucci; Barbara Pichi; Giuseppe Iaccarino; Paolo Ruscito; Giuseppe Sprian πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 223 KB πŸ‘ 2 views

## Abstract ## Background The acute toxicity of intraoperative radiation therapy (IORT) delivered as an β€œearly boost” after tumor resection in patients with locally advanced head and neck cancer was evaluated. ## Methods Twenty‐five patients were enrolled in the study. All patients underwent sur